§ PHARMACEUTICALS
USD · PharmaceuticalsEOLS
EVOLUS INC
USDSector · PharmaceuticalsBeta · 1.33
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
13F FLOW
96 increased/new, 40 decreased/exited (13F)
AC 13F Analysis
§ 04 · FUNDAMENTALS · THE BOOKS
| P/B | 126.60 | EPS (TTM) | -0.67 |
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| Nantahala Capital Management, LLC | 6.4M | 1.0% | +10% |
| BlackRock, Inc. | 4.3M | 0.0% | +5% |
| BRAIDWELL LP | 3.1M | 0.4% | ±0% |
| Frazier Life Sciences Management, L.P. | 2.6M | 0.3% | ±0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.5M | n/a | n/a |
| Soleus Capital Management, L.P. | 2.2M | 0.4% | +110% |
◇ AC INTELLIGENCE
Top institutional owners for EOLS as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER22.5% · 0 holders
OTHER53.4% · 101 holders
PASSIVE / INDEX9.7% · 8 holders
DEALER / BANK7.4% · 18 holders
TACTICAL / MACRO3.5% · 2 holders
SYSTEMATIC / QUANT1.9% · 8 holders
ACTIVIST0.9% · 1 holder
QUALITY / COMPOUNDER0.4% · 5 holders
INCOME / DEFENSIVE0.2% · 6 holders
DEEP VALUE0.1% · 1 holder
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for EOLS in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
No notes mention EOLS yet.